- Home
- OBT vs AQST Comparison
OBT vs AQST Comparison
Compare OBT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- AQST
- Stock Information
- Founded
- OBT 1892
- AQST 2004
- Country
- OBT United States
- AQST United States
- Employees
- OBT N/A
- AQST N/A
- Industry
- OBT Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- AQST Health Care
- Exchange
- OBT Nasdaq
- AQST Nasdaq
- Market Cap
- OBT 368.1M
- AQST 390.4M
- IPO Year
- OBT N/A
- AQST 2018
- Fundamental
- Price
- OBT $24.75
- AQST $5.97
- Analyst Decision
- OBT Buy
- AQST Strong Buy
- Analyst Count
- OBT 1
- AQST 7
- Target Price
- OBT $29.00
- AQST $10.29
- AVG Volume (30 Days)
- OBT 45.9K
- AQST 3.5M
- Earning Date
- OBT 10-29-2025
- AQST 11-03-2025
- Dividend Yield
- OBT 2.10%
- AQST N/A
- EPS Growth
- OBT N/A
- AQST N/A
- EPS
- OBT 2.57
- AQST N/A
- Revenue
- OBT $105,510,000.00
- AQST $44,132,000.00
- Revenue This Year
- OBT $18.34
- AQST N/A
- Revenue Next Year
- OBT $6.14
- AQST $51.50
- P/E Ratio
- OBT $9.66
- AQST N/A
- Revenue Growth
- OBT 2.48
- AQST N/A
- 52 Week Low
- OBT $20.97
- AQST $2.12
- 52 Week High
- OBT $33.06
- AQST $6.43
- Technical
- Relative Strength Index (RSI)
- OBT 39.90
- AQST 64.34
- Support Level
- OBT $24.50
- AQST $5.47
- Resistance Level
- OBT $26.48
- AQST $5.93
- Average True Range (ATR)
- OBT 0.60
- AQST 0.36
- MACD
- OBT -0.15
- AQST 0.02
- Stochastic Oscillator
- OBT 10.00
- AQST 72.12
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.